ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation System

Monday, November 16, 2015

Submitted by

Mark Ferguson

Source

Source Name: Annals of Thoracic Surgery

Source URL: http://www.annalsthoracicsurgery.org/article/S0003-4975%2815%2901195-9/abstract

Author(s)

Jonathan M. Philpott, Christian W. Zemlin, James L. Cox, Mack Stirling, Michael Mack, Robert L. Hooker, Allen Morris, David A. Heimansohn, James Longoria, Divyakant B. Gandhi, Patrick M. McCarthy

The report of FDA-mandated prospective evaluation of outcomes after Cox Maze-IV for atrial fibrillation during cardiac surgery for other problems. It utilized the Synergy ablation system and focused on absence of AF off antiarrhythmics at 6 months and the absence of major adverse events at 30 days. 76% were AF free, and 9.1% experienced major complications. Results were comparable to the cut-and-sew technique of the Cox Maze-III procedure.